Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bartosch

Showing results (171-180 of 248) with videos related to

Pageof 25
Sort By:
Oncotarget|December 25, 2015
Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometriumCarla Bartosch, Sara Monteiro-Reis, Diogo Almeida-Rios, et al.
Cancers|October 3, 2020
Gene Panel Tumor Testing in Ovarian Cancer Patients Significantly Increases the Yield of Clinically Actionable Germline Variants beyond <i>BRCA1</i>/<i>BRCA2</i>Ana Barbosa, Pedro Pinto, Ana Peixoto, et al.
Hepatology (Baltimore, Md.)|October 27, 2005
Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activityDarren J Schofield, Birke Bartosch, Yohko K Shimizu, et al.
Biochemical and Biophysical Research Communications|January 14, 2017
Hepatitis C virus alters metabolism of biogenic polyamines by affecting expression of key enzymes of their metabolismOlga A Smirnova, Tuomo A Keinanen, Olga N Ivanova, et al.
Gynecologic Oncology|June 4, 2026
Clinical relevance of homologous recombination repair gene alterations in endometrial cancer patients in the era of molecular classificationSara Neves Carvalho, Inês Soldin, Raquel Mugeiro Silva, et al.
International Journal of Environmental Research and Public Health|March 10, 2022
Occurrence of No-Harm Incidents and Adverse Events in Hospitalized Patients with Ischemic Stroke or TIA: A Cohort Study Using Trigger Tool MethodologyBartosch Nowak, René Schwendimann, Philippe Lyrer, et al.
Frontiers in Genetics|September 20, 2023
Combined germline and tumor mutation signature testing identifies new families with <i>NTHL1</i> tumor syndromeCarla Pinto, Joana Guerra, Manuela Pinheiro, et al.
Journal of Virology|April 29, 2005
Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infectionDimitri Lavillette, Yoann Morice, Georgios Germanidis, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2003
In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopesBirke Bartosch, Jens Bukh, Jean-Christophe Meunier, et al.
The Journal of General Virology|March 22, 2007
Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitorsCynthia Chapel, Céline Garcia, Birke Bartosch, et al.
Pageof 25

Showing results (171-180 of 248) with videos related to

Sort By:
Pageof 25
Oncotarget|December 25, 2015
Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometriumCarla Bartosch, Sara Monteiro-Reis, Diogo Almeida-Rios, et al.
Cancers|October 3, 2020
Gene Panel Tumor Testing in Ovarian Cancer Patients Significantly Increases the Yield of Clinically Actionable Germline Variants beyond <i>BRCA1</i>/<i>BRCA2</i>Ana Barbosa, Pedro Pinto, Ana Peixoto, et al.
Hepatology (Baltimore, Md.)|October 27, 2005
Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activityDarren J Schofield, Birke Bartosch, Yohko K Shimizu, et al.
Biochemical and Biophysical Research Communications|January 14, 2017
Hepatitis C virus alters metabolism of biogenic polyamines by affecting expression of key enzymes of their metabolismOlga A Smirnova, Tuomo A Keinanen, Olga N Ivanova, et al.
Gynecologic Oncology|June 4, 2026
Clinical relevance of homologous recombination repair gene alterations in endometrial cancer patients in the era of molecular classificationSara Neves Carvalho, Inês Soldin, Raquel Mugeiro Silva, et al.
International Journal of Environmental Research and Public Health|March 10, 2022
Occurrence of No-Harm Incidents and Adverse Events in Hospitalized Patients with Ischemic Stroke or TIA: A Cohort Study Using Trigger Tool MethodologyBartosch Nowak, René Schwendimann, Philippe Lyrer, et al.
Frontiers in Genetics|September 20, 2023
Combined germline and tumor mutation signature testing identifies new families with <i>NTHL1</i> tumor syndromeCarla Pinto, Joana Guerra, Manuela Pinheiro, et al.
Journal of Virology|April 29, 2005
Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infectionDimitri Lavillette, Yoann Morice, Georgios Germanidis, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2003
In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopesBirke Bartosch, Jens Bukh, Jean-Christophe Meunier, et al.
The Journal of General Virology|March 22, 2007
Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitorsCynthia Chapel, Céline Garcia, Birke Bartosch, et al.
Pageof 25